Ticagrelor and prasugrel are independent predictors of improved long‐term survival in ACS patients

AIM: To investigate the long‐term clinical benefit of dual antiplatelet therapy with potent P2Y12 inhibitors compared to clopidogrel in patients with acute coronary syndrome (ACS). METHODS: In this prospective multicenter observational study, we enrolled 708 patients with ACS treated with clopidogre...

Descripción completa

Detalles Bibliográficos
Autores principales: Gager, Gloria M., Jilma, Bernd, Winter, Max‐Paul, Hengstenberg, Christian, Lang, Irene M., Toma, Aurel, Prüller, Florian, Wallner, Markus, Kolesnik, Ewald, von Lewinski, Dirk, Siller‐Matula, Jolanta M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685125/
https://www.ncbi.nlm.nih.gov/pubmed/32506444
http://dx.doi.org/10.1111/eci.13304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685125/
https://www.ncbi.nlm.nih.gov/pubmed/32506444
http://dx.doi.org/10.1111/eci.13304

Ejemplares similares